Global Vaccine Distribution

The conversation delves into the manufacturing landscape of vaccines, highlighting the dominance of mRNA technology in North America and Europe, while other platforms like AstraZeneca's are being produced in countries such as India and Brazil. COVAX emerges as a crucial initiative aimed at ensuring global vaccine equity, addressing historical disparities in access for poorer nations. Despite its aspirations, significant challenges have arisen in its implementation, reflecting the complexities of global health logistics.